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JENKINS, J.M., ET AL.: Use of the pill electrode for Iransesophageal atrial pacing. The pill electrode,
which was developed for esophageal electrocardiography, has found application in transesophageal
atrial pacing during procedures such as conversion of tachycardia, electrophysiologic measurement,
and ucceieralion 0/ heart rate to produce stress during cardiac imaging studies. This paper presents
theoretical studies that examine the relationship 0/ intereJectrode distance, current levej, and pulse
duration lo (he achievement of successful capture. Theoretical results agree with our clinical findings,
i.e., current levels of 25 niA are effective to sustain capture; increosed puJse duration reduces current
requirements; and close bipolar spacing combines efficacy with safety. Results 0/ animal studies
performed to assess the extent of esophageal burn injury reveal thaf current levels in excess of 75 mA
are required to produce lesions in short-term (under 30 minutes] pacing, and greater than GO niA in
long-terjii (4 hours) pacing. 7 hese results are based on experiments using a pulse duration of 2 ms, and
the current levels that produce injury will he considerably lower if longer pulse durations are used.
Typical current levels and puise durations for successful capture are presented for 46 subjects in several
new clinical applications. Termination 0/ tachycardia, basic electrophysiologic measurements, and
controlled acceleration 0/heart rafe can be performed noninvasiveiy with this technique. (PACE, Vol. 8,
/uly-August, 1985)
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Introduction
The recently developed pill electrode, widely
used for esophageal electrocardiography, can also
be employed for short-term transesophageal left
atrial pacing. Thus, it is possible to perform a
variety of procedures in which atrial pacing can
be done noninvasiveiy with minimal time and
patient disc:omfort. These procedures include:
initiation and termination of tachycardia, delivery
of single and multiple extrastimuli for the mea-
surement of electrophysiologic and hemodynamic
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response, and acceleration of heart rate to produce
stress during imaging studies of ventricular func-
tion. In this last application, transesophageal pac-
ing can provide more precise control of heart
rate during echocardiographic, radiographic, or
nuclear imaging than can be obtained with ex-
ercise: it also eliminates image degradation
due to patient movement. These applications
prompted us to study the theoretical basis of
transesophageal atrial pacing, its safety in animals,
and some new clinical applications.
Background
Several groups interested in atrial pacing have
sought to avoid the discomfort, time, and cost of
venous catbeterization by introducing the pacing
electrode through the nose or mouth down into
tbe esophagus to tbe level of tbe heart. Early
efforts to pace the heart^ ^ were limited for one
of four reasons: (1) the studies were done in dogs,
wbose thoracic geometry is such tbat the esopb-
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ageal-cardiac approximation is poor: (2) the effort
concentrated on pacing the human ventricle,
which is not particularly close to the esophagus;
(3) unipolar electrodes were used and the "indif-
ferent" electrode caused undesirable stimulation
of chest and diaphragmatic musculature; and (4)
the stimulator employed did not dehver enough
current.
Later studies concentrated on atrial pacing in
humans using bipolar electrodes and high-voltage
stimulators,^"^^ and had successful left atrial cap-
ture at currents between 10 and 30 mA u^ith rare
ventricular or chest muscle stimulation. These
studies and our own preliminary studies^"'" dem-
onstrate the technical feasibility of transesopha-
geal pacing and suggest that broader application
may develop quickly. Nevertheless, there are
three important aspects of transesophageal pacing
that have not been adequately addressed and
that are important to its future usefulness as a
diagnostic and therapeutic technique: {1) the
physical and mathematical principles underlying
the method have not been presented, so that
users may lack a clear understanding of several
important parameters of the technique, including
choice of bipolar spacing, effect of electrode po-
sition, and current and voltage requirements; (2)
how the discomfort of nasogastric intubation may
limit the acceptability of the technique; and (3)
the lack of animal studies done to assess the risk
of electrical burning of the esophagus. The present
study was designed to address these deficiencies.
Theoretical Principles
The current density required to pace the heart
from electrodes in proximity to excitable tissue
can be estimated by first considering a configu-
ration that is known to be effective and that is
easily described mathematically, i.e.. a conducting
ring on a catheter in contact with the endocar-
dium, as shown in Figure 1. For such an electrode,
the current density at its surface is given by the




where I is the current, d and 1 are the electrode
diameter and length, and J is the current density
at the electrode surface. Equation 1 is exact in a
homogeneous medium for a cylinder that is long
compared to its radius. In our case, the length-
to-radius ratio is 4:1 and the endocardium and
intracavitary blood have essentially the same
resistivity, so the equation provides a reasonable





Figure 1. Drawing of a cylindrical catheter electrode in conlact with the endocardia/ surface
ofthe right atrium. Current density (}} present in adjacenf tissue is determined by the amplitude
of current (IJ delivered, divided by area of the eleclrode surface, (d = diameter, J = lengthj
PACE, Vol. 8 July-August 1985 513
JENKINS. ET AL.
trode, these numbers are I ^ 1 mA. d - 2.5 mm.
1 = 6 mm. The resulting current density. 20 MA/
mm^, provides a fairly accurate estimate of the
current density actually present in endocardia]
tissue during catheter pacing. The 1 mA current
would be adequate for a stimulation pulse of 1-
2 ms, which is typical in catheter pacing. (Inho-
mogeneity and boundary effects, which compli-
cate such calculation in the usual thoracic volume
conductor studies of theoretical electrocardiology.
are of little significance in this case, since the
electrode is close to the structure heing stimu-
lated.)
The esophageal case is shown in Figure 2. We
postulate a 10 mm distance from esophagus to
left atrium and assume the same 1 mA current
source delivered to a small spherical unipolar
esophageal electrode in a homogeneous medium.
The current density is
ESOPHAGUS
0.8 fiA/mm' [2)
where R is the distance in millimeters from the
center of the small electrode to excitahle tissue.
Similarly, for a bipolar esophageal electrode lo-
cated at the same distance from the left atrium
and with 13 mm interelectrode spacing [Fig. 3),
it can be shown that
bl
= 0.61 M/mm^ [3]
where b is the bipolar electrode spacing and R is
the distance from the midpoint of the electrode
to the nearest excitable tissue on the midplane






Figure 2. Schematic of unipoJar pacing electrode within the esophagus shown with eslimaled
dislance from nearest atrial surface. Current density (/J within (he Je/1 atrium is inversely related
Io the square of the distance (R) from electrode to atrial excitable (issue.
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Figure 3. Bipolar esophageal eleclrode showing relationship of current density (/) to interelectrode
spacing (b) and distance from excitahle tissue (R). Point p represents closest atrial myocardium
on (he midplane of electrode. If electrode is positioned such that closest afrial tissue is not
located on bipolar midplane (p'), the angle of displacement ^ is a /actor in the current density
calculation. See equation 4 in (ext. (/ = curren(j
and 3 indicates that the current density delivered
to the atrium hy an esophageal electrode is about
1/25 that from an intracavitary lead. In addition,
the current density from the unipolar electrode
is perpendicular to the tissue, whereas that from
the bipole would be tangential to the left atrium.
It may be that current densities perpendicular to
fibers are more effective in stimulating the tissue.
On the other hand, atrial muscle does not have
preferential direction, and so even the tangential
current density will he perpendicular to many
atrial fibers. Source currents of up to 25 mA
appear to be necessary in an esophageal electrode
to produce a cardiac current density sufficent to
pace the heart. (Our preliminary experimental
results in over 40 patients and volunteers have
confirmed the theoretical conclusion that 25 mA
is required to capture the atrium with a pulse
duration of 1 ms; wider pulses reduce the re-
quired current.)
Equation 3 can also be used to derive an
optimal relationship hetween the bipolar spacing
b and distance from the electrode R to obtain
maximum current density when the electrode is
properly positioned within the esophagus as close
as possible to the left atrium. That relationship
is b - V2R = 1.4R. Thus the interelectrode
spacing can he optimized for particular anatom-
ical cases. In infants, for example, left atrial
myocardium may be witbin 5 mm of the esoph-
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agus. and a bipolar spacing of 7 mm would
produce the theoretically maximum current den-
sity at the atrium, Note that for distances in the
usual adult range (10 mm), a bipolar spacing of
14 mm is optimal for pacing the left atrium with
minimal current, reducing the risk of accidental
ventricular stimulation and producing the least
discomfort. We have found that for spacings
within 5 mm of optimal, the current density at
the atrial distance is within 10% of the maximum.
For larger spacings (30 mm or more), the current
density decreases sharply at the electrode mid-
plane. For this case, capture will be more easily
achieved if the bipolar electrode is moved from
a symmetric position relative to the atrium to a
position where either pole is adjacent to the
excitahle tissue and the other is remote. This
situation essentially represents unipolar pacing
and is likely to result in inadvertent stimulation
of other structures.
Cardiac locations above or below the hipolar
midplane of Figure 3 suffer a further loss of
current density not shown in equation 3. The
general expression for this case is too complex
to provide physiologic insight, but the following
approximation exists for the current density when
the distance from the electrode is large compared




where 6 is the angle above the electrode midplane
(Fig, 3} and the other symbols are as previously
defined. Equation 4 reveals the important fact
that when the distance from the electrode to the
heart is much greater than the interelectrode
spacing, the current density falls off inversely
with the cube of distance, thus explaining why
bipolar pacing minimizes inadvertent stimulation
of remote structures. Even in the case where the
distance is not much greater than the interelec-
trode spacing, the current density falls off dra-
matically. For example, in adults, the nearest
ventricular surface is at least 3 cm from the
esophagus, which is three times the distance of
the posterior left atrial wall from the esophagus.
For this case, detailed calculations from equation
4 reveal that a closely spaced bipolar esophageal
electrode positioned for atrial pacing would pro-
duce ventricular current densities with only ^
the strength of those produced in the left atrium.
Similarly, pectoral and diaphragmatic muscula-
ture are relatively insensitive to properly posi-
tioned bipolar transesophageal pacing.
Unfortunately, these proximity effects that are
well known for closely spaced bipolar electrodes
and are described concisely in equation 4 present
a requirement for very careful positioning, as
compared to unipolar or wide bipolar configura-
tions. Loss of atrial capture can occur when a
bipolar pacing electrode moves only a few cen-
timeters.
We have also considered an esophageal/chest
bipolar electrode combination for transthoracic
pacing. From the viewpoint of the left atrium,
such a configuration is essentially unipolar and
has no advantages. Current levels of about 25
mA are painful to the skin and produce uncom-
fortable excitation of skeletal muscles. The
esophageal mucosa is much less sensitive and
only minor discomfort is experienced with bipolar
pacing at 25 mA. On the other hand, if ventricular
pacing is intended, the distance of the ventricle
from the esophagus averages 4 cm and unipolar
electrodes, both thoracic and esophageal. will
require less current than bipolar esophageal elec-




The pill electrode,* which was designed orig-
inally for esophageal recording of the atrial elec-
trogram,^''^^ is shown in Figure 4, It consists of
two conducting members whose centers are 13
mm apart, and thus it is theoretically optimal for
pacing tissues at a distance of 9.4 mm from the
esophagus. The electrode is attached to a twisted
pair of very thin threadlike. Teflon-insulated.
stainless steel wires. It is enclosed in an ordinary
pharmaceutical gelatin capsule. The patient is
instructed to swallow the capsule with water
while the nurse or technician gradually releases
the wire and allows the capsule to descend.
Within a few moments the capsule dissolves and
peristalsis has lowered the electrode to a level
below the left atrium (approximately 40 cm from
the teeth). At this time, the wire pair is connected
' Arzco Medical Electronics. Inc., Chicago, IL. USA.
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Figure 4. Drawing of the swallowabie esuphageai electrode encased in a gelatin capsule. The
pill electrode is a closely spaced bipolar pair, suspended from a pair of thin flexible wires. The
electrode passes into the eosphagus ivilh a sivalloiv of water followed by additional swaJlowing
until il is positioned immediately posterior to Ihe atrium.
to an electrocardiograph and slowly withdrawn
a few centimeters at a time until the electrode is
at an optimal level for atrial pacing. This level is
indicated by a P-to-QRS ratio of 2 or 3 to 1 on
the electrocardiogram (this ratio is an excellent
indicator of left atrial approximation; radiography
is unnecessary).
Figure 5 is an esophageal recording showing
the P-wave progressively emerging as the elec-
trode is gradually raised from a low ventricular
to a high atrial position. The atrial spikes are
negative at first and increasing in amplitude.
Then, there is a sudden change in polarity. This
is the position where the nearest atrial myocar-
dium is on the midplane of the electrode. When
the electrode is properly positioned, the wire is
taped to the patient's chin to prevent further
peristaltic lowering and its connector is removed
from the electrocardiograph and connected to
the stimulator to begin pacing. Throughout this
procedure, there is little gagging or consciousness
of the fine flexible wire, so that the swallowing,
recording, and positioning procedure is virtually
innocuous.
Stimulator
The stimulator used for transesophageal atrial
pacing must possess certain unique characteris-
tics. As described in the theoretical section of
this paper, the currents typically required for
consistent capture range from 15 to 25 mA. We
measured the voltage during pacing at various
currents and found that it is not strictly propor-
tional to current delivered. Voltage also varies
during swallowing, respiration, and changes in
posture. If one defines the electrode impedance
to be the ratio of voltage to current of the pacing
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• 1 1 1
r
LEAD I I
Figure 5. Two-channel tracing showing esophageal lead during positioning. The top channel
is the esophageal electrogram and the lower channel a surface lead II. The esophageal lead is
being ivithdrawn from helow the ventricle (far left portion of tracing) to a position immediately
posterior to the left atrium {far right portion of (racing). Note the progressively emerging P-
wave which, when optimally located, shows a 2.5:1 ratio with respect to the esophageal QRS.
pulse, tho impedance of the pill electrode ranges
from 1.000 to 2.000 ohms or more probably due
to uncertain contact with the esophageal wall
with its higher resistivity. Since atrial capture
depends on current density in the excitable tissue,
not voltage at the electrodes, the stimulator must
provide a constant current over a wide range of
impedances. It can be seen that the output voltage
developed by the device can rise to 75 volts or
more; therefore existing stimulators designed for
endocardial pacing at impedances significantly
less than 1.000 ohms will not have the voltage
capability to drive an esophageai electrode at 15
to 25 m A regardless of the rated current capability
of the unit. Existing stimulators are typically
battery-operated with a voltage limitation of 9.
18. or. at the most. 27 volts.
It is a well-known physiological observation
that the pulse duration necessary to generate a
propagated action potential in remote tissue is
much longer than the 0.5 to 1 ms stimulus
duration required when the electrode is in contact
with tho excitable tissue. Distances of about 10
mm exist between the esophagus and nearest
excitable atrial tissue and thus wide stimulus
pulses will be required. Our experimental findings
which will be discussed in the next section
demonstrate that the threshold of stimulus
strength required for capture approaches the
rheobase^^ as the pulse duration approaches 10
ms. In most of our experiments we have used a
stimulator designed specifically for esophageal
pacing (Arzco Medical Electronics) that can pro-
vide a constant current pulse of 0 to 40 mA and
up to 10 ms width at pacing rates from 30 to 480
per minute. In addition to this fixed mode of
operation, the stimulator can also be used as a
high current output stage for a programmable
electrophysiologic stimulator.
Animal Studies
In vitro and in vivo experiments were per-
formed in 55 dogs in order to assess the extent
of burn injury to the esophagus caused by pacing
with the pill electrode. These experiments con-
form to the principles of the American Physio-
logical Society for experimental animal studies.
In the in vitro series (25 dogs), the esophagus
was excised, the electrode was inserted, and
stimulation was performed for periods of 20 to
240 minutes with a rate of 60 to 120 beats per
minute, pulse duration of 2 ms. and current of
20 to 120 mA. Multiple stimulations were per-
formed using each esophageal specimen. After
stimulating, the esophagus was examined for
gross evidence of burning or ulceration. In the
in vivo series (30 dogs), the animals were anes-
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thetizod with 30 mg/kg of Nembutal and respired
with room air. The esophagus was exposed via
an approach medial to the common carotid artery
and a suture was placed on the muscularis ex-
terna of the esophagus for later location of the
point of stimulation. With the aid of a catheter
as a guide, the pill electrode was inserted through
the mouth into the esophagus to a point under
the suture, as verified by palpation. The wire
was then taped to the snout to prevent peristalsis
from moving the electrode, and care was taken
to insure that the esophagus was in its natural
position relative to the other tissues of the neck.
Prior to stimulation, a muscle relaxant (Syn-
curine or Flaxedil) was administered and supple-
mented as necessary during stimulation to pre-
vent skeletal muscle contractions from moving
the electrode (the agents had no visible effect
upon the contraction of the esophagus). The
esophagus was stimulated for 10, 30, or 240
minutes at 60 or 120 pulses/min with a 2 ms
pulse duration and current of 20. 60, or 80 mA.
After stimulation, the position of the electrode
relative to the suture was again verified by pal-
pation. Ten of the dogs were sacrificed immedi-
ately, while in each of the other 20 dogs, the
wound was closed and the animal was allowed
1 to 3 days to recover so that inflammatory
responses could develop and the extent of natural
healing could be assessed.
When the esophagus was removed, it was
rinsed of mucus, photographed, and examined
grossly. In 25 of 30 in vivo experiments, the
esophagus was then opened, rinsed of mucus,
placed on filter paper, photographed, and fixed
in buffered formalin. Following fixation for at
least 24 hours, sections were taken of any lesions
noted, with a diagram indicating the location of
each lesion and the corresponding section. At
least one section of apparently normal esophagus
was also taken. In the event no lesion was evident
on gross examination or with the aid of a hand
lens, the entire circumference of the esophagus
at the level of the electrode was taken (four to
five strips of wall at 2 to 3 millimeters in thickness
were embedded in paraffin block) and the entire
area examined microscopically.
Clinical Studies
Tables I and II list the 46 subjects in whom we
attempted transesophageal atria! pacing with the
pill electrode or. in the nine children not old
enough to swallow a capsule, with a catheter
electrode introduced through the nose. This pro-
cedure was approved by our institutional review
board and informed consent was obtained, Once
initiated, pacing was continued for a period suf-
ficient to perform either an electrophysiologic
(EP) protocol or an imaging study. The EP studies
consisted of determination of strength-duration
curves for pacing thresholds, measurement of
sinus node recovery time, and/or initiation and
termination of supraventricular tachycardia. The
imaging studies included radionuclide visualiza-
tion of ventricular emptying sequences during
normal and anomalous pathway activation, ra-
dionuclide ventriculography during pacing-in-
duced stress, and/or echocardiography during
pacing-induced stress.
Electrophysioiogic Applications
In ten subjects, detailed strength-duration
curves were obtained by noting the minimum
current at which sustained capture was obtained
at 2. 4. 6. 8. and 10 ms pulse duration. Current
at which moderate patient discomfort occurred
was also noted. In four subjects, sinus node
recovery time was measured following standard
electrophysiologic procedure; after 60 seconds of
pacing at rates from 90 to 150 beats per minute.
the pacing was terminated ahruptly and the
interval was measured between the last paced
beat and the subsequent sinus escape beat.
Ten children with sustained reentrant supra-
ventricular tachycardia, aged 1 week to 16 years,
were treated with transesophageal overdrive
atrial pacing on 16 different occasions. In the 16-
year-old patient, the pill electrode was used; in
the others, nasogastric intubation was required.
The three children under 1 year of age were
sedated with chloral hydrate and slept through
the procedure; one 2-year-old child (the first
patient in this study) received general anesthesia;
the remaining patients were either unsedated (1
patient) or received Valium (=S5 mg IV) for seda-
tion. Atrial flutter was present among five of the
patients and recurrent supraventricular tachy-
cardia in the other five. Transesophageal pacing
was used to initiate as well as terminate the
tachyarrhythmia in one of these five patients.
Initial current strength and pulse duration were
4 mA and 4 ms. respectively. Pulse duration was





















































































































































































































































PSVT/SVT paroxysmal/supraventricular tachycardia; WPW = Wolff-Parkinson-White syndrome; AF = atrial
flutter; TERM = termination; S/D =• strength-duration; NA - not applicable; -f = successtui; * - variable.
increased by a 1 ms increment and current by 1
mA to a maximum of 10 ms and 20 niA. respec-
tively, until atrial capture was achieved. Once
capture was achieved, pacing for 10-30 s was
begun at successively shorter (by 10 ins) drive
cycle lengths until the tachycardia was inter-
rupted or atrial refractoriness was reached.
Imaging Applications
Radionuclide ventriculography was performed
during transesophageal pacing in seven patients
with conduction abnormalities, in 12 patients
with suspected coronary artery disease, and in 5
normal control subjects. At pulse durations of 3-
15 ms, current was increased until stable atrial
capture occurred with a constant 1:1 stimulus-
to-QRS relationship at a rate 20-30 beats faster
than the sinus rate. This was continued for at
least 3 minutes and, for the coronary artery
disease group, was repeated at faster heart rates
[120. 140, 160 beats per minute) until completion
of the final stage of stress or occurrence of chest
pain. In the conduction abnormality group, the
images acquired during pacing were subjected to
phase analysis'" in order to study the emptying
sequence of the heart during normal and acces-
sory pathway conduction. In the coronary artery
disease group, images were obtained to determine
the effect of pacing rate on ejection fraction.
regional wall motion, relative ventricular vol-
umes, and indices of diastolic filling (first-third
filling time, peak filling rate, time-to-peak filling
rate). In two normal subjects. M-mode echocar-
diograms were recorded at 1-minute intervals as
the esophageal pacing rate was increased in order
to observe changes in ventricular wall thickening,
percent fractional shortening, and rate of short-
ening.
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WPW = Wolff-Parkinson-White syndrome; SVT = supraventricular tachycardia; CAD = coronary artery disease;
RVG - radionuclide ventriculography; Echo = echocardiography; Cone/path = concealed pathway.
Results
Safety
In our animal experiments, esophagus that was
excised with the original mucus undisturbed and
then stimulated in vitro for 20 minutes required
more than 100 mA to produce a visihle lesion;
with longer stimulation times, lesions occurred
at lower currents: fiO minutes required 75 mA
and 240 minutes required 60 mA to produce
lesions. In the first five in vivo experiments, gross
examination of the esophagus showed that 100
mA is required to produce burn injury after 10
minutes of stimulation and this heals within 3
days. Histoiogical examination in the remaining
25 in vivo studies demonstrated that epithelial
erosion can occur after stimulation at 60 mA for
4 hours, hut is repaired in 24 to 48 hours. In
addition, an inflammatory response may develop
within 24 hours that involves the suhmucosal
mucus ducts. Perforation or stricture does not
occur and appears unlikely to develop. When the
60 mA stimulation was limited to 30 minutes (10
dogs), there was no evidence of mucosal ulcera-
tion or necrosis, although local infiltrates of neu-
trophils were found in otherwise intact mucosa
and suhmucosa. These neutrophilic infiltrates
were ohserved in and around mucus ducts. This
is an occasional finding in normal control animals
and was ohserved in sections taken from grossly
uninvolved areas distant from the site of stimu-
lation in the experimental animals.
In our clinical experiments. 43 of the 46 suh-
jects who consented to transesophageal pacing
were successfully paced for a period sufficient to
perform one or more of the studies described
above. There were no reports of discomfort in
swallowing or positioning the pill electrode, and
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high quality recordings were obtained in all cases
without difficulty. The chief complaint during
pacing was of a sensation of moderate to severe
"pulsatile heartburn'" that disappeared immedi-
ately upon cessation of pacing. There were no
reports of post-stimulation discomfort or pain
upon swallowing.
EJecfrophysio/ogic AppJications
Figure 6 is the strength-duration curve that
shows the average transesophageal current nec-
essary to effect sustained capture at pulse dura-
tions of 2-10 ms in 10 adults paced via the pill
electrode. In terms of the Lapicque formulation.
the strength-duration curve can be approximated
by I - 12.24 mA (1 + 3.12 ms/t), p of 0.992 with
a chronaxie of 3.12 ms and a rheobase of 12.24
mA. The total variation in current is also shown.
The current level at which discomfort was re-
ported ranged from 15 to 25 mA and appeared to
be only slightly affected by pulse durations, with
wider pulses usually but not always producing
discomfort at lower currents. Sinus node recovery
times measured in four adults are summarized
in Table III.
The results for tachycardia termination in the
ten children are given in Table I. Transesophageal
pacing was successful in terminating supraven-
tricular tachycardia during all 16 tachycardia
episodes in the ten patients. Mean current level
for capture was 14.2 mA (range 8-20 mA), and
mean pulse duration was 5.9 ms (range 3-10).
Mean charge was 88.69 ^C (range 32 to 200 fiC).
Threshold parameters [current strength and pulse
duration) were not related to age or size. The
STRENGTH-DURATION CURVE













Figure 6. Mean strength-duration curve for (en normaJ subjects. The mean (±SD) current level
at which sustained capture was achieved al each af five selected pulse durations is plotted in
(his graph.
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mean arrhythmia cycle length was 219 ms (range,
190-250 ms). The mean pacing cycle length used
during overdrive pacing to terminate the tachy-
cardia was 170 ms (150-214 ms). The mean
pacing cycle length necessary to terminate the
tachycardia was 78% of the mean tachycardia
cycle length. Figure 7 shows supraventricular
tachycardia which was converted by a train of
transesophageal stimuli delivered for 3.8 seconds
at a cycle length of 180 ms. The top channels are
leads I and II and the third channel is an esoph-
ageal eiectrogram. Upon cessation of pacing, the
tachycardia converts to sinus rhythm. The only
complication encountered in our studies was
passage of the catheter into the trachea inducing
paroxysms of coughing in one patient; this prob-
lem was immediately identified and the catheter
was withdrawn. It was then properly positioned
within the esophagus and successful conversion
was performed.
Imaging Applications
Table II summarizes the results of transesopha-
geal atrial pacing during imaging procedures. The
first 24 subjects underwent radionuclide ventric-
ulography and subjects 25 and 26 were imaged
by ecbocardiography. Patients 6 to 12 were the
subject of an earlier report'" that described the
use of phase analysis for imaging. However, the
detailed transesophageal pacing data have not
been presented previously. In the four patients
with electrophysiologically documented accessory
pathways, transesophageal pacing induced a su-
praventricular tachycardia and therefore could
be discontinued during radionuclide ventriculog-
raphy, while in the remaining three patients and
in four of the five control subjects, pacing was
maintained throughout the image acquisition pe-








Figure 7. Transesophageal (ESO) atrial overdrive pacing in an infant wiih paroxysmal
supraventricuJar tachycardia (SVT). The left-hand side of tbe /igure demonstrates SVT with
recording of both a transesophageal atrial (a) and a ventricular (v) electrogram. A train of
transesophageal stimuli (s) were delivered for 3.8 seconds at a cycle Jength of 180 ms; at
terminalion of pacing, sinus rhythm appeared (righl-hand side of figure).
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remaining subject at current levels he would
tolerate. In the five normal subjects and the four
subjects in whom supraventricular tachycardia
was induced, phase analysis of images obtained
during pacing revealed a similar pattern of emp-
tying to that obtained during sinus rhythm. Of
the three patients in whom pacing was main-
tained and tachycardia was not induced (all had
Wolff-Parkinson-White syndrome), phase maps
were obtained that localized the site of pre-
excitation and concealed pathways. For the seven
subjects in this study in whom transesophageal
pacing was maintained, mean current level was
19.3 mA (range, 12-23 niA) and pulse duration
7.8 ms (range. 5-15 ms). Mean charge was 128.9
nC (range. 90-184 ^C).
In ten ofthe 12 coronary artery disease patients
in whom radionuclide ventriculograms were used
to examine ventricular function, transesophageal
atrial pacing via the pill electrode was successful
in providing stress without patient movement
and high quality images were obtained. Target
heart rates for all four stages were achieved in
eight of ten patients. Mean charge was 139.4 fj.C
(range, 60-250 nQ. Mean current level was 20.2
mA (range. 15-30 mA) and pulse duration was
7.25 ms (range. 3-10 ms). Similarly, elevated
heart rate was easy to establish in echocardio-
graphic imaging in two subjects, resulting in
excellent M-mode quality. Mean current level
was 17 mA and pulse duration was 6.5 ms with
a mean charge of 110 ^C. For all subjects in
Table II for whom capture was sustained, the
mean charge was 129.4 fiC ± 46.9.
Discussion
Two of our theoretical conclusions have been
substantiated by our clinical results: that currents
of about 25 mA are effective and that the very
close bipolar spacing of the pill electrode does
not compromise efficacy. The first of these con-
clusions is in agreement with recent investiga-
tions.̂ ^" '̂ However, the second conclusion appears
to be contrary to the position of Gallagher^'' who
concluded that 30 mm was the optimal spacing
in seven patients, but agrees with the most recent
work of Benson,^" who found no significant dif-
ference between 15. 22, and 28 mm in his 30
patients. Our theoretical study suggests that the
results found by others who used widely spaced
electrodes represent a positioning of the electrode
with one pole adjacent to the atrium and thus
the pacing was essentially unipolar. The question
of interelectrode spacing is an important one
because close spacing protects against unintended
stimulation of the ventricle, diaphragm, and chest
and because it allows pharmaceutical encapsu-
lation, thus eliminating the discomfort of intu-
bation which, as Benson notes.'^ is more objec-
tionable than the discomfort of stimulation.
It should be pointed out again that careful
electrocardiographic positioning is a firm re-
quirement of close bipolar transesophageal pacing
and that proper depth of insertion cannot be
achieved by using markings on the wire (or
catheter) together with radiographic or physical
estimates of left atrial location. Even in individual
patients, we have found differences in optimal
insertion depth due to simple variations in seated
posture, and even larger differences when a su-
pine position is assumed. (We have occasionally
observed that higher currents may be necessary
when the patient is in a supine position even if
the electrode appears to be optimally located
electrocardiographically.) Andersen and Pless^''
have recently recommended positioning at a fixed
distance above the gastroesophageal junction in
all patients, using a balloon distal to the electrodes
for location and fixation at the gastric sphincter.
We are not in agreement with this recommen-
dation and prefer precise electrocardiographic
positioning in all cases.
Risk of Esophageai Injury
We have concluded from our animal experi-
ments that in short-term pacing (under 30 min-
utes) with pulse durations of 2 ms. 75 to 100 mA
will produce lesions, which appear to heal in 3
days. At longer pacing times (4 hours). 60 mA
will produce similar epithelial erosions as well
as inflammation involving the submucosal ducts.
In the absence of mucosal destruction or ulcera-
tion. morbidity from these lesions seems unlikely.
It appears clear that there is little or no risk of
burn injury in short-term, low-current pacing
(under one-half hour, less than 40 mA) at pulse
durations less than or equal to 2 ms. but pacing
for more than 4 hours may involve some risk.
Also, pulse durations greater than 2 ms have not
been studied and so these limits of current and
pacing time should be lower if 5-10 ms pulses
are used.
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One of the normal subjects included in this
study consented to endoscopy before and on the
first day after esophageal pacing and a second
subject on the first day after. No evidence of
coagulation necrosis was observed. Unfortunately.
the discomfort associated with endoscopy was
enormously greater than that associated with pill
electrode swallowing and pacing, so that consent
for an endoscopic procedure was not requested
of our other subjects. In a 1972 study of trans-
esophageal pacing in 92 patients.^ endoscopy was
performed in 18. Tbe only esophageal injuries
noted were small decubital lesions in two pa-
tients, one of whom had been paced for 30 hours.
These were interpreted as pressure necroses due
to the nasogastric catheter used for pacing, rather
than coagulation necroses. The patient in sinus
arrest who was paced by Burack and Furman^
for 36 hours showed, at autopsy, only pressure
necrosis caused by the nasogastric tube. Our
animal results also suggest that short-term (one-
half hour) pacing at currents less than 40 mA at
pulse durations less than 2 ms is safe.
We are beginning to adopt the intuitively ap-
pealing position that the use of increased pulse
duration to reduce current results in the least
patient discomfort although this opinion bas not
been confirmed by systematic study. This may
increase the risk of esophageal injury and our
dog studies performed with 2 ms stimuli should
be repeated for longer pulse durations. With this
slight reservation, it appears that temporary
transesophageal pacing during the brief proce-
dures described here is quite free of risk of
esophageal burning, On the other hand, the safety
of the technique for long-term support of a patient
in sinus arrest, prior to permanent pacemaker
implantation, cannot be presumed on the basis
of our studies.
With respect to patient discomfort, the chief
sensation elicited was an intermittent "heart-
burn" that was well tolerated for the length of
the procedure. Although no subject described
the sensation as painful, some were apprehensive
and uncomfortable. No patient suffered ill effects
from electrical stimulation of the esophagus and
we are not aware of any short-term or long-
term complications. Nevertheless, the technique
should be attempted only with equipment that
allows careful control of current levels and en-
sures patient isolation from line voltages.
AppJicdtions
The theoretical and experimental evidence of
reentry as the mechanism of many forms of
supraventricular tachycardia, including atrial
flutter, has been convincingly demonstrated.^^"^^
and has resulted in a renewed interest in the
role of overdrive pacing to terminate these ar-
rhythmias.^^"^^ Overdrive pacing through either
intracardiac, transthoracic. or transesophageal
routes has been widely used in many clinical
situations,'"'"'^''"^'^ and is especially important in
the development of antiarrhythmia pacemakers
as well as proper selection of candidates for these
implanted devices. Transesophageal overdrive
pacing offers several advantages: the technique
offers virtually universal noninvasive access to
the atrium; it can be performed in an outpatient
setting; it requires minimal or no sedation; and
there is little discomfort. It is important to note
tbat three additional patients, not included in
the tachycardia conversion group, were diagnosed
by surface electrocardiogram as having atrial
flutter; however, atrial recordings from the
esophageal electrodes demonstrated atrial fibril-
lation. Therefore inappropriate overdrive pacing
was not attempted.
Our experience with the use of transesophageal
atrial pacing for initiation and termination of
supraventricular tachycardia has been in children
in whom venous catheterization is difficult, costly,
and time consuming, particularly when repeated
studies are done and appropriate vessels large
enough to catheterize cannot be easily or safely
accessed. Thus, our successful (10 of 10) use of
the transesophageal route, like Benson's"*'^'^"
promises a bright future for tbe technique. In
adults, the ability to use the pill electrode instead
of a nasogastric tube provides additional advan-
tage to the transesophageal route, Intracardiac
pacing techniques will remain the definitive ap-
proach to arrhythmia and conduction disturbance
elucidation; however, there is much appeal for a
noninvasive alternative, particularly for sequen-
tial studies involved in serial drug testing.
A simple, noninvasive procedure using esoph-
ageal pacing coupled to radionuclide ventriculog-
raphy had been shown to be of value in deter-
mining the site of pre-excitation in patients with
Wolff-Parkinson-White syndrome and concealed
accessory pathways.'** Scintigraphic phase maps
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agreed with electrophysiologic maps in localizing
the pre-excited sites and concealed pathways.
The technique may prove to be a valuable prelude
to electrophysiology studies in patients who are
surgical candidates for ablation of the bypass
tract. The use of intracardiac atrial pacing to
provide stress in the evaluation of patients with
coronary artery disease has been extensively
investigated using radiographic procedures in the
catheterization laboratory.^''^^ The radionuclide
ventriculogram is ideally suited to provide many
of the same diagnostic measurements of ventric-
ular function.'"*-̂ '̂  and thus the use of esophageal
pacing during either radionuclide ventriculogra-
phy or echocardiography provides a substitute
for physiological stress, exercise, and the invasive
risks of catheterization. The method allows com-
plete control of heart rate independent of patient
cooperation. Furthermore, the constant RR inter-
val and resulting uniform diastolic filling provide
images superior even to those obtained during
rest. Moreover, it is applicable in patients who
are unable to achieve intense levels of exercise.
including patients with symptomatic claudication,
unstable angina pectoris. chronic obstructive
pulmonary disease, and patients taking drugs
that produce )3-blockade.
Several important aspects of transesophageal
pacing have been presented, particularly the un-
derlying theoretical principles and results of an-
imal studies to assess the risk of esophageal
injury. These give insight into the relationship
of interelectrode distance, current level, and pulse
duration to the achievement of successful capture
with minimal risk and discomfort to the patient.
Several new clinical applications bave been de-
scribed and preliminary results are discussed.
The use of a miniature pill electrode encased in
a pharmaceutical capsule obviates the need for
bulky nasogastric tubes or intracardiac catheters
and reduces many of these applications to out-
patient procedures, Termination of tachycardia,
basic electrophysiologic measurements, and con-
trolled acceleration of heart rate represent pro-
cedures that can be performed noninvasiveiy
with this technique.
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